Linked Life Data

11050453

Source:http://linkedlifedata.com/resource/pubmed/id/11050453

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-12-1
pubmed:abstractText
Utilizing genome sequence data from bacterial and fungal pathogens for the discovery of new antimicrobial agents has received considerable attention, both practical and critical, from the pharmaceutical and biotechnological communities. Although no new drugs derived from genomics-based discovery have been reported to be in a development pipeline, the utilization of genomics has revolutionized many aspects of drug discovery. The application, utility, opportunity, and challenges afforded by many of these new approaches are discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1369-5274
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
522-7
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Will genomics revolutionize antimicrobial drug discovery?
pubmed:affiliation
Department of Chemotherapy and Molecular Genetics, Schering-Plough Research Institute, 2015 Galloping Hill Road, K-15-4700, Kenilworth, NJ 07974-1300, USA. Todd.Black@spcorp.com
pubmed:publicationType
Journal Article, Review